12:00 AM
 | 
Dec 16, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System regulatory update

Boston Scientific said FDA approved its Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System for coronary artery disease (CAD). The product, which is immediately available, is an everolimus-eluting...

Read the full 117 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >